Moshe Alafi, Ten Percent Owner at Intra-Cellular Therapies, holds 3.60M shares in Intra-Cellular Therapies (Ticker: ITCI), holds 2.33M shares in Stereotaxis (Ticker: STXS). Most recently, Moshe Alafi Bought ― shares of Intra-Cellular Therapies on Oct 03, 2017 for an estimated value of 4.00M.
What is the percentage of profitable transactions made by Moshe Alafi?
The percentage of profitable transactions made by Moshe Alafi is 78%.
What is the average return per transaction made by Moshe Alafi?
The average return per transaction made by Moshe Alafi is 145.10%.
What stocks does Moshe Alafi hold?
Moshe Alafi holds: ITCI, STXS stocks.
What was Moshe Alafi’s latest transaction?
Moshe Alafi latest transaction was an Informative Buy of $4.00M.
What was Moshe Alafi's most profitable transaction?
Moshe Alafi’s most profitable transaction was an Informative Buy of ITCI stock on November 28, 2014. The return on the trade was 308.90%.
What is Moshe Alafi's role in Intra-Cellular Therapies?
Moshe Alafi's role in Intra-Cellular Therapies is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.